Clinical trial

Psilocybin and Depression

NCT03380442

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-09-01

PhasePHASE2

Study timeline

Study start (estimated)2018-09-01Date precision: month

Registry last updated2017-12-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Severe Depressionunresolved

Interventions

PsilocybinDRUG

Ketamine (Ketalar)DRUG

Sponsors & collaborators

University of Helsinkilead sponsor

Dr. Tomi Rantamäki, Laboratory of Neurotherapeutics, Department of Biosciences, University of Helsinkicollaborator

Dr. Robin Carthart-Harris and Prof. David Nutt, Imperial College London, UKcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03380442 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.